AlphAIAlphAI — Financial news for AI agents
SEC EDGARSEP 221 min read$NVMI

Wolfing Shay sold $1.4M of NVMI

Wolfing Shay (CTO) sold 3,864 shares of NOVA LTD. (NVMI) at $363.28 ($1.40M total) on 2026-09-21 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Wolfing Shay
Published Sep 22, 2026, 1:04 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 22, 2026, 1:18 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$NVMI
Bearish
medium confidence
Mentioned
$NVMI
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$NVMIBearishLow
01

Why it matters

The CTO's sale reduces insider ownership, which may be interpreted by the market as a lack of confidence, though it could be a pre‑planned liquidity event.

02

Market read

Primary disclosure of a significant insider sale; modest trading relevance for NVMI shareholders.

03

What to watch

Potential upcoming corporate actions or personal tax planning not disclosed.

Relevance 5/10Novelty 5/10Timing: post‑market filing on 2026‑09‑22

Background

Form 4 filing discloses insider transactions required by SEC regulations.

Company-level read

Ticker impact

$NVMIBearishMedium confidence
Context

CTO Wolfing Shay sold 3,864 shares for $1.4M via a 10b5-1 plan, reducing his stake to 21,409 shares.

Expected impact

Possible modest dip in NVMI price over the next few days.

Evidence & confidence

CTO is a senior insider; sale size is notable for a micro‑cap, but no other catalyst is present.

Market effects

Sector

Minimal impact on the broader biotech sector.

Regional

Limited to investors tracking NVMI.

Global

None

Counterpoint

What could challenge this read

The sale could be a routine liquidity move, not a negative signal.

Key entities

  • Company
    NOVA LTD.

    Biotech company listed under ticker NVMI.

  • Insider
    Wolfing Shay

    Chief Technology Officer of NOVA LTD.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

NVMI insider trading history →

Related articles

SEP 7
$NVMIMedAI 8/10

Nova (NVMI) Just Blew Past $250M In Quarterly Sales

Nova (NVMI) reported Q2 2026 revenue of $255M, up 8% QoQ and 16% YoY, with GAAP net income of $75M and non-GAAP net income of $86.5M. GAAP EPS was $2.20, up from $2.04 QoQ and $2.14 YoY. Non-GAAP EPS was $2.51, up from $2.33 QoQ and $2.20 YoY. The company guided Q3 2026 revenue to $277M-$287M, GAAP EPS to $2.46-$2.61, and non-GAAP EPS to $2.70-$2.85. Gross margin declined to 56.5% from 57.7% QoQ and 57.8% YoY.

yahoo.com2 min
SEP 1
$ESLTMed

Tue: Rate cut lifts market

The Tel Aviv Stock Exchange rose after the Bank of Israel cut interest rates to 3.25%. The Tel Aviv 35 Index gained 0.22%, while Dimri led gains with a 5.47% rise. OPC Energy fell 4.67%, the biggest decline. Key movers included Elbit Systems, Teva, and Ormat, which rose, and Camtek and Tower Semiconductor, which fell.

en.globes.co.il2 min
AUG 6
$NVMIHigh

NOVA LTD. (NVMI): Financial results for Q2 2026

NOVA LTD. (NVMI) furnished an SEC Form 6-K — earnings release. Attached hereto and incorporated by way of reference herein is a press release issued by the Registrant and entitled: “Nova Reports Record Second Quarter 2026 Financial Results”. The GAAP financial statements tables included in the press release attached hereto are hereby incorpo

SEC EDGAR 6-K2 min